Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

ClinicalTrials.gov ID: NCT03391765

Public ClinicalTrials.gov record NCT03391765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03391765
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

  • ABBV-8E12 Drug
  • Placebo solution for IV infusion on Day 15 Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2018
Primary completion
Dec 12, 2019
Completion
Dec 12, 2019
Last update posted
Feb 2, 2021

2018 – 2019

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Univ Alabama-Birmingham /ID# 165522 Birmingham Alabama 35294
Mayo Clinic Arizona /ID# 165521 Phoenix Arizona 85054
Cedars-Sinai Medical Center /ID# 165567 Beverly Hills California 90211
Usc /Id# 165529 Los Angeles California 90033
University of California, Los Angeles /ID# 165669 Los Angeles California 90095
University of California, San /ID# 165560 San Diego California 92037
Univ California, San Francisco /ID# 165553 San Francisco California 94143-2204
Rocky Mountain Movement Disorders Center /ID# 165559 Englewood Colorado 80113-2736
UF Center for Movement Disorde /ID# 165561 Gainesville Florida 32607
Mayo Clinic /ID# 165554 Jacksonville Florida 32224
University of South Florida /ID# 165556 Tampa Florida 33612
Augusta University Medical Center /ID# 165562 Augusta Georgia 30912-0004
Rush University Medical Center /ID# 165527 Chicago Illinois 60612
University of Chicago Medical /ID# 165555 Chicago Illinois 60637
Indiana University /ID# 165519 Indianapolis Indiana 46202
University of Kentucky Chandler Medical Center /ID# 165566 Lexington Kentucky 40536
Mayo Clinic - Rochester /ID# 165518 Rochester Minnesota 55905-0001
Cleveland Clinic Lou Ruvo Cent /ID# 165538 Las Vegas Nevada 89106
Rutgers Robert Wood Johnson /ID# 165526 New Brunswick New Jersey 08901
Columbia Univ Medical Center /ID# 165528 New York New York 10032-3725
Cleveland Clinic Main Campus /ID# 165537 Cleveland Ohio 44195
Vanderbilt Univ Med Ctr /ID# 165520 Nashville Tennessee 37232-0011
Kerwin Research Center /ID# 206872 Dallas Texas 75231-4316
McGovern Medical School /ID# 165565 Houston Texas 77054

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03391765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03391765 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →